학술논문

Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2.
Document Type
Article
Source
Clinical Genetics. Mar2005, Vol. 67 Issue 3, p261-266. 6p.
Subject
*METALLOPROTEINASES
*GENETIC mutation
*SKELETON
*BONE resorption
*ARABS
*GENETIC disorders
*DISEASES
Language
ISSN
0009-9163
Abstract
Zankl A, Bonafé L, Calcaterra V, Di Rocco M, Superti-Furga A. Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2.The inherited osteolysis syndromes are a heterogeneous group of skeletal disorders whose classification is still uncertain. Three osteolysis syndromes show autosomal recessive inheritance and multicentric involvement: Torg syndrome (OMIM 259600), Winchester syndrome (OMIM 277950) and Nodulosis–Arthropathy–Osteolysis syndrome (NAO; OMIM 605156). The 2001 Nosology of the International Skeletal Dysplasia Society (Hall CM, Am J Med Genet 2002: 113: 65) classifies NAO as a variant of Torg syndrome, while Winchester syndrome is considered as a separate disorder. Recently, mutations in the matrix metalloproteinase 2 (MMP2) gene were identified in affected individuals with a clinical diagnosis of NAO in two Arab families. We report a homozygous missense mutation (E404K) in the active site ofMMP2in a 21-year-old woman with a severe form of osteolysis best compatible with a diagnosis of Winchester syndrome. The clinical and molecular findings suggest that Torg, NAO and Winchester syndromes are allelic disorders that form a clinical spectrum. [ABSTRACT FROM AUTHOR]